KATHERINE REYER: Open Payments
NPI 1841877636 · BRANDON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,533 in 148 payments from 25 companies in 2025. Trend: 2023 $3,427 · 2024 $3,409 · 2025 $3,533
Food & beverage: $3,499Education: $34
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 38 | $601 |
| AstraZeneca Pharmaceuticals LP | 13 | $362 |
| Grifols USA, LLC | 12 | $337 |
| Inspire Medical Systems, Inc. | 3 | $271 |
| Insmed, Inc. | 11 | $262 |
| GENZYME CORPORATION | 5 | $175 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $169 |
| Philips North America LLC | 5 | $155 |
| Amgen Inc. | 9 | $152 |
| JAZZ PHARMACEUTICALS INC. | 5 | $138 |
Products named: NUCALA, Prolastin-C Liquid, INSPIRE, TEZSPIRE, Arikayce, TRELEGY ELLIPTA, DUPIXENT, GLASSIA.
Industry payments across FL — which companies pay providers there.
